Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis

被引:75
作者
Allen, Claire [1 ]
Hopewell, Sally [2 ]
Prentice, Andrew [3 ]
Gregory, Daisy [1 ]
机构
[1] Cochrane Collaborat Secretariat, Oxford OX2 7LG, England
[2] UK Cochrane Ctr, Oxford, England
[3] Rosie Matern Hosp, Dept Obstet & Gynaecol, Cambridge, England
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2009年 / 02期
关键词
Anti-inflammatory agents; non-steroidal [*therapeutic use; Endometriosis [complications; *drug therapy; Female; Humans; Pain [*drug therapy; etiology;
D O I
10.1002/14651858.CD004753.pub3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Endometriosis is a common gynaecological condition that affects women and can lead to painful symptoms and infertility. It greatly affects women's quality of life, impacting on their careers, everyday activities, sexual and non-sexual relationships, and fertility. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most commonly used first-line treatment for endometriosis. Objectives To assess the effects of NSAIDs used for the management of pain in women with endometriosis compared to placebo, other NSAIDs, other pain management drugs, or no treatment. Search strategy We searched the Cochrane Menstrual Disorders and Subfertility Group Trials Register (April 2008) published in the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), MEDLINE (1966 to April 2008), EMBASE (1980 to April 2008), and the reference lists from relevant publications. Experts in the field were also contacted for information about possible studies. Selection criteria We included all randomized controlled trials (RCTs) describing the use of NSAIDs in the treatment of endometriosis in women of all ages. Data collection and analysis Two review authors (CA and SH) independently read and extracted data from each of the included studies. Crossover trials were analysed using the inverse variance method in RevMan to calculate the odds ratio for binary outcomes. Main results Two trials were identified but only one trial, with 24 women, was included in the analysis. Comparing NSAIDs (naproxen) to placebo, there was no evidence of a positive effect on pain relief (odds ratio (OR) 3.27, 95% CI 0.61 to 17.69) in women with endometriosis.There was also inconclusive evidence to indicate whether women taking NSAIDs (naproxen) were less likely to require additional analgesia (OR 0.12, 95% CI 0.01 to 1.29) or to experience side effects (OR 0.46, 95% CI 0.09 to 2.47) when compared to placebo. Authors' conclusions There is inconclusive evidence to show whether or not NSAIDs (naproxen) are effective in managing pain caused by endometriosis. There is no evidence on whether any individual NSAID is more effective than another. As shown in other Cochrane reviews, women using NSAIDs need to be aware of the possibility that these drugs may cause unintended effects.
引用
收藏
页数:23
相关论文
共 20 条
[1]  
[Anonymous], 1985, Fertil Steril, V43, P351
[2]   ENDOMETRIOSIS 1990 - CURRENT TREATMENT APPROACHES [J].
BARBIERI, RL .
DRUGS, 1990, 39 (04) :502-510
[3]   Characteristics related to the prevalence of minimal or mild endometriosis in infertile women [J].
Bérubé, S ;
Marcoux, S ;
Maheux, R .
EPIDEMIOLOGY, 1998, 9 (05) :504-510
[4]   Managing endometriosis - Strategies to minimize pain and damage [J].
Canavan, TP ;
Radosh, L .
POSTGRADUATE MEDICINE, 2000, 107 (03) :213-+
[5]   The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis [J].
Cobellis, L ;
Razzi, S ;
De Simone, S ;
Sartini, A ;
Fava, A ;
Danero, S ;
Gioffrè, W ;
Mazzini, M ;
Petraglia, F .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2004, 116 (01) :100-102
[6]  
Davies B., 2003, COMMUNICATION 0430
[7]  
DAWOOD MY, 1986, ACTA OBSTET GYN SCAN, P7
[8]   Meta-analyses involving cross-over trials: methodological issues [J].
Elbourne, DR ;
Altman, DG ;
Higgins, JPT ;
Curtin, F ;
Worthington, HV ;
Vail, A .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (01) :140-149
[9]   NON-STEROIDAL ANTI-INFLAMMATORY DRUGS - CURRENT STATUS AND RATIONAL THERAPEUTIC USE [J].
HART, FD ;
HUSKISSON, EC .
DRUGS, 1984, 27 (03) :232-255
[10]   Health-related quality of life measurement in women with common benign gynecologic conditions: A systematic review [J].
Jones, GL ;
Kennedy, SH ;
Jenkinson, C .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 187 (02) :501-511